Norav Medical Mobile ECG is a diagnostic tool for medical professionals that turns iOS devices into 12-lead electrocardiographs when connected to specific Norav hardware.
The App DNA
What makes this app unique?
The app removes the need for bulky, stationary ECG equipment in clinical settings by enabling portable, diagnostic-grade cardiac testing via mobile devices.
For Medical professionals and clinical institutions requiring portable, diagnostic-grade cardiac monitoring and ECG management.
What does it look like?
Key features
Transforms mobile devices into clinical-grade diagnostic electrocardiographs when paired with NR-1207-3 or NR1207-E hardware.
Provides automated ECG analysis and measurement logic for clinical decision support.
Supports PDF and raw file exports, FTP transfer, and connectivity with Norav NEMS-Q management systems.
How much does it cost?
The app functions as a free utility interface for proprietary hardware, with revenue generated through the sale of medical diagnostic devices.
Velocity
Maintenance developmentUX improvementsShow more...
The app maintains a maintenance-tier cadence, with only one release shipped in the last 38 days. Development is currently focused on specific functional improvements for data logging rather than rapid feature iteration. Given the current release frequency, the app shows a stable but slow development pace. Future updates are expected to continue at this infrequent interval.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Norav Medical Mobile ECG
How's the Health & Fitness market?
Norav Medical Mobile ECG serves a professional clinical audience, with its utility defined by regulatory certifications (FDA 510k, CE 2797) rather than consumer-facing chart rankings.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Norav Medical Mobile ECG
Where is it heading?
The market for professional-grade mobile diagnostics is consolidating around hardware-software bundles that meet strict regulatory standards. Norav Medical Mobile ECG remains advantaged by its existing FDA and CE certifications, ensuring it stays relevant for clinical users despite a slow update cadence.
- The latest release added CSV export options, confirming the app remains in a maintenance cycle focused on data utility rather than feature expansion.
The SWOT
- Proprietary hardware integration creates high switching costs
- FDA 510k and CE 2797 certifications ensure clinical trust
- Localized language expansion for emerging clinical markets
Next best moves
Audit clinical integration stability because the app serves as a medical diagnostic tool → maintain professional trust
The counter-intuitive read
The app's lack of consumer-facing engagement is a feature, not a bug…
Read the full takeSince the last report: The app has shifted its public-facing narrative to emphasize its professional B2B utility and hardware-dependent nature, while refining its SWOT analysis to better account for market visibility and regulatory strengths.
Bottom line
Norav Medical Mobile ECG maintains its position by anchoring clinical workflows to proprietary hardware, ensuring that the diagnostic utility remains tied to the device ecosystem.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
Report last updated